First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantationRizwan Romee, Jeffrey S. Miller, Sarah Cooley et al.|Blood|2018Cited by 406
miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1Changming Lu, Xianzheng Zhou, Xin Huang et al.|Blood|2011Cited by 272
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHDBenjamin Watkins, Leslie S. Kean, Muna Qayed et al.|Journal of Clinical Oncology|2021Cited by 247
The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In VivoAlison M. Paterson, Arlene H. Sharpe, Anil Chandraker et al.|The Journal of Immunology|2011Cited by 205
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune Woan, Frank Cichocki, Hansol Kim et al.|Cell stem cell|2021Cited by 153